tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ionis Pharmaceuticals price target raised to $86 from $71 at Morgan Stanley
PremiumThe FlyIonis Pharmaceuticals price target raised to $86 from $71 at Morgan Stanley
12d ago
Ionis Pharmaceuticals price target raised to $83 from $81 at BofA
Premium
The Fly
Ionis Pharmaceuticals price target raised to $83 from $81 at BofA
12d ago
Ionis Pharmaceuticals price target raised to $92 from $90 at Guggenheim
Premium
The Fly
Ionis Pharmaceuticals price target raised to $92 from $90 at Guggenheim
12d ago
Ionis Pharmaceuticals Reports Positive Study Results for Zilganersen
PremiumCompany AnnouncementsIonis Pharmaceuticals Reports Positive Study Results for Zilganersen
13d ago
Ionis Pharmaceuticals reports zilganersen study met primary, secondary endpoints
Premium
The Fly
Ionis Pharmaceuticals reports zilganersen study met primary, secondary endpoints
13d ago
Ionis Pharmaceuticals: Strategic Positioning and Growth Potential with Olezarsen’s EU Approval and Promising sHTG Market Prospects
Premium
Ratings
Ionis Pharmaceuticals: Strategic Positioning and Growth Potential with Olezarsen’s EU Approval and Promising sHTG Market Prospects
13d ago
Ionis Pharmaceuticals price target raised to $80 from $70 at RBC Capital
PremiumThe FlyIonis Pharmaceuticals price target raised to $80 from $70 at RBC Capital
1M ago
Ionis Pharmaceuticals’ Olezarsen Shows Strong Potential in Billion-Dollar Market, Earning Buy Rating from Analyst
Premium
Ratings
Ionis Pharmaceuticals’ Olezarsen Shows Strong Potential in Billion-Dollar Market, Earning Buy Rating from Analyst
1M ago
Why Did IONIS Stock (IONS) Surge to a Four-Year High?
Premium
Market News
Why Did IONIS Stock (IONS) Surge to a Four-Year High?
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100